Patient Guide: A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 30 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05298254
Status: ACTIVE_NOT_RECRUITING
Condition: Herpes Simplex
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 30 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Wichita, Kansas
  • • Kansas City, Missouri
  • • And 27 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes - Join Clinical Trial NCTNCT05298254

How to Join This Clinical Trial - NCTNCT05298254

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Herpes Simplex. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Herpes Simplex. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Herpes Simplex
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05298254 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 30 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85015 - United States

Status: Contact for availability

Clinical Research Site

Wichita, Kansas 67207 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Missouri 64114 - United States

Status: Contact for availability

Clinical Research Site

Rochester, New York 14609 - United States

Status: Contact for availability

Clinical Research Site

Richmond, Virginia 23219 - United States

Status: Contact for availability

Clinical Research Site

Seattle, Washington 98105 - United States

Status: Contact for availability

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: Contact for availability

Clinical Research Site

Sydney, New South Wales 2010 - Australia

Status: Contact for availability

Clinical Research Site

Antwerpen, 2000 - Belgium

Status: Contact for availability

Clinical Research Site

Brussels, 1000 - Belgium

Status: Contact for availability

And 20 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Herpes Simplex:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships